Myriad Genetics Inc. SWOT, Financial and Strategic Analysis Report 2025

Published On: Aug, 2025
|
Pages: 55

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing test to help determine the therapy for patients with metastatic breast, ovarian, metastatic pancreatic, or metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic Test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. The company also offers Prolaris Prostate Cancer Prognostic Test, a RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic Test, a RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor, a solution for precision oncology; and Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus. In addition, it provides Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; and GeneSight Psychotropic Mental Health Medication Test, a DNA genotyping test to aid psychotropic drug selection for patients suffering from depression, anxiety, ADHD, and other mental health conditions. Myriad Genetics, Inc. has a strategic collaboration with Illumina, Inc. and Intermountain Precision Genomics for an offering of germline and somatic tumor testing services. The company was founded in 1991 and is headquartered in Salt Lake City, Utah. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Myriad Genetics Inc..

Myriad Genetics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Myriad Genetics Inc. are also analyzed.

Detailed SWOT Analysis of the company including key strengths and weaknesses of Myriad Genetics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.

Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.

Financial analysis of Myriad Genetics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Myriad Genetics Inc. and all latest updates of the company are provided.

The 2025 version of Myriad Genetics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.

TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures

2 Introduction to the Company
 2.1 Myriad Genetics Inc.- Key Facts
 2.2 Myriad Genetics Inc.- Geographic Locations
 2.3 Myriad Genetics Inc.- Subsidiaries and Affiliates
 2.4 Myriad Genetics Inc.- Business Divisions
 2.5 Myriad Genetics Inc.- Key Employees
 2.5.1 Management Team
 2.5.2 Board of Directors
 
3. Myriad Genetics Inc. Strategic Analysis Review
 3.1 Myriad Genetics Inc.- Key Strategies
 3.2 Myriad Genetics Inc.- Company Outlook Statement
 3.3 Myriad Genetics Inc.- SWOT Analysis
 3.3.1 Myriad Genetics Inc.- Key Strengths
 3.3.2 Myriad Genetics Inc.- Key Weaknesses
 3.3.3 Myriad Genetics Inc.- Potential Opportunities
 3.3.4 Myriad Genetics Inc.- Potential Threats
 3.4 Myriad Genetics Inc.- Key Competitors

4. Business Description of the Company
 4.1 Myriad Genetics Inc.- Business Overview
 4.2 Myriad Genetics Inc.- Operations by Segment

5 Products and Services Details
 5.1 Myriad Genetics Inc.- Key Products
 5.2 Myriad Genetics Inc.- Key Service Areas
 5.3 Myriad Genetics Inc.- Key Brands

6 Company Developments
 6.1 Myriad Genetics Inc.- Company History
 6.2 Myriad Genetics Inc.- Latest Developments

7 Financial Analysis
 7.1 Myriad Genetics Inc.- Income Statements
 7.2 Myriad Genetics Inc.- Balance Sheet
 7.3 Myriad Genetics Inc.- Cash Flow Statements

8 Competitors and Industry Analysis
 8.1 Myriad Genetics Inc.- Direct Competitors
 8.2 Myriad Genetics Inc.- Competitor Financial Ratios comparison
 8.3 Myriad Genetics Inc.- Competitor Stock Charts Comparison
 8.4 Myriad Genetics Inc.- Industry Analysis
 
9 Appendix
 9.1 About SWOTreports
 9.2 Sources and Methodology
 9.3 Contact Information

P.S.Financial Analysis will be provided only for companies reporting financial data.

Get Free Sample

At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.

Start Now! Please fill the form below for your free sample.

Why Request a Free Sample?

Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.

Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.

Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.

Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.

You can purchase individual sections of this report. Explore pricing options for specific sections.

FAQ's

Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.

Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.

Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.

License

$50- 50%

$100- 30%

$200- 30%

$100- 30%

Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM

Need something within your budget? NO WORRIES! WE GOT YOU COVERED!

Related Products

Johnson & Johnson SWOT, Financial and Strategic Analysis Report 2025

"Johnson & Johnson Company Profile is a detailed strategic and analytical report on Johnson & Johnson. The 2025 version of the report offers detailed insights into the company’s strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Johnson & Johnson. Johnson & Johnson business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Johnson & Johnson are also analyzed. Detailed SWOT Analysis of the company including key strengths and weaknesses of Johnson & Johnson, on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed. Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided. Financial analysis of Johnson & Johnson including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of the Johnson & Johnson and all latest updates of the company are provided. The 2024 version of the Johnson & Johnson report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format."

Published:Mar-2025

10x Genomics Inc.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of 10x Genomics Inc.. 10x Genomics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of 10x Genomics Inc. are also analyzed. Detailed SWOT Analysis of the company including key strengths and weaknesses of 10x Genomics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed. Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided. Financial analysis of 10x Genomics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of 10x Genomics Inc. and all latest updates of the company are provided. The 2025 version of 10x Genomics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.

Published:Jun-2025

180 Life Sciences Corp.

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of 180 Life Sciences Corp.. 180 Life Sciences Corp. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of 180 Life Sciences Corp. are also analyzed. Detailed SWOT Analysis of the company including key strengths and weaknesses of 180 Life Sciences Corp. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed. Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided. Financial analysis of 180 Life Sciences Corp. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of 180 Life Sciences Corp. and all latest updates of the company are provided. The 2025 version of 180 Life Sciences Corp. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.

Published:Jun-2025